HC Wainwright Raises Verona Pharma (NASDAQ:VRNA) Price Target to $90.00
Verona Pharma (NASDAQ:VRNA – Get Free Report) had its price objective raised by analysts at HC Wainwright from $85.00 to $90.00 in a research report issued to clients and investors on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. HC Wainwright’s price objective indicates a potential upside of 6.12% from the […]
More Stories
Rob Reiner’s Son Booked for Murder After Director, Wife Found Dead
By Zachary Stieber Nick Reiner has been taken into custody following the death of his parents, Rob and Michele Reiner....
Tomorrow’s Jobs Report to Test the Resilience of the US Labor Market
By Andrew Moran The November jobs report will be released on Dec. 16, revealing the health of the U.S. labor...
US Officials Identify National Guardsmen Killed in ISIS Attack in Syria
By Jack Phillips The two U.S. military members killed over the past weekend in central Syria were Iowa Army National...
Police Detain Person of Interest in Deadly Brown University Shooting
By Jacob Burg A person of interest is in custody over the shooting at Rhode Island’s Brown University on Saturday...
Trump Honors US ‘Miracle on Ice’ Hockey Team in White House Celebration
By Travis Gillmore WASHINGTON—President Donald Trump hosted members of the 1980 U.S. Olympic hockey team at the White House on...
Hero at Sydney Mass Shooting Approaches Gunman From Behind, Disarms Him
By Naziya Alvi Rahman A beachgoer who tackled and disarmed one of the gunmen has become an unexpected hero of...